BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16932241)

  • 21. The effect of soy-derived isoflavones over hot flushes, menopausal symptoms and mood in climacteric women with increased body mass index.
    Chedraui P; San Miguel G; Schwager G
    Gynecol Endocrinol; 2011 May; 27(5):307-13. PubMed ID: 20528204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isoflavone treatment for acute menopausal symptoms.
    Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
    Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Menopause: a review of botanical dietary supplements.
    Low Dog T
    Am J Med; 2005 Dec; 118 Suppl 12B():98-108. PubMed ID: 16414334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of soyfoods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency.
    Messina M; Hughes C
    J Med Food; 2003; 6(1):1-11. PubMed ID: 12804015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized placebo-controlled trial of an isoflavone supplement and menopausal symptoms in women.
    Baber RJ; Templeman C; Morton T; Kelly GE; West L
    Climacteric; 1999 Jun; 2(2):85-92. PubMed ID: 11910672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review.
    Booth NL; Piersen CE; Banuvar S; Geller SE; Shulman LP; Farnsworth NR
    Menopause; 2006; 13(2):251-64. PubMed ID: 16645539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological activities of Genistein, an isoflavone from soy (Glycine max): part II--anti-cholesterol activity, effects on osteoporosis & menopausal symptoms.
    Suthar AC; Banavalikar MM; Biyani MK
    Indian J Exp Biol; 2001 Jun; 39(6):520-5. PubMed ID: 12562012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigation of the reliability of 24 h urine excretion as a biomarker of isoflavone exposure over time and over a wide range of isoflavone intakes.
    Ritchie MR; Morton MS; Thompson AM; Deighton N; Blake A; Cummings JH; Steel CM
    Eur J Clin Nutr; 2004 Sep; 58(9):1286-9. PubMed ID: 15054404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Red-clover-derived isoflavones and mammographic breast density: a double-blind, randomized, placebo-controlled trial [ISRCTN42940165].
    Atkinson C; Warren RM; Sala E; Dowsett M; Dunning AM; Healey CS; Runswick S; Day NE; Bingham SA
    Breast Cancer Res; 2004; 6(3):R170-9. PubMed ID: 15084240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Daidzein-rich isoflavone-aglycones for menopausal symptoms.
    Ricciotti HA; Khaodhiar L; Blackburn GL
    Int J Gynaecol Obstet; 2005 Apr; 89(1):65-6. PubMed ID: 15777908
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study.
    D'Anna R; Cannata ML; Atteritano M; Cancellieri F; Corrado F; Baviera G; Triolo O; Antico F; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Marini H; Squadrito F
    Menopause; 2007; 14(4):648-55. PubMed ID: 17251874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Soy protein and isoflavone effects on vasomotor symptoms in peri- and postmenopausal women: the Soy Estrogen Alternative Study.
    Burke GL; Legault C; Anthony M; Bland DR; Morgan TM; Naughton MJ; Leggett K; Washburn SA; Vitolins MZ
    Menopause; 2003; 10(2):147-53. PubMed ID: 12627040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis.
    BolaƱos R; Del Castillo A; Francia J
    Menopause; 2010; 17(3):660-6. PubMed ID: 20464785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double-blind, placebo-controlled study.
    D'Anna R; Cannata ML; Marini H; Atteritano M; Cancellieri F; Corrado F; Triolo O; Rizzo P; Russo S; Gaudio A; Frisina N; Bitto A; Polito F; Minutoli L; Altavilla D; Adamo EB; Squadrito F
    Menopause; 2009; 16(2):301-6. PubMed ID: 19034051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effects of a proprietary combination isoflavone nutritional supplement in menopausal women: a pilot trial.
    Lukaczer D; Darland G; Tripp M; Liska D; Lerman RH; Schiltz B; Bland JS
    Altern Ther Health Med; 2005; 11(5):60-5. PubMed ID: 16189949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoflavone Supplements for Menopausal Women: A Systematic Review.
    Chen LR; Ko NY; Chen KH
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial.
    Crawford SL; Jackson EA; Churchill L; Lampe JW; Leung K; Ockene JK
    Menopause; 2013 Sep; 20(9):936-45. PubMed ID: 23511704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Phytoestrogens and menopausal symptoms].
    Madsen S
    Tidsskr Nor Laegeforen; 2009 Nov; 129(21):2238-9. PubMed ID: 19898572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of isoflavones and amino acid therapies for hot flashes and co-occurring symptoms during the menopausal transition and early postmenopause: a systematic review.
    Thomas AJ; Ismail R; Taylor-Swanson L; Cray L; Schnall JG; Mitchell ES; Woods NF
    Maturitas; 2014 Aug; 78(4):263-76. PubMed ID: 24951101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of a Hatha yoga treatment for menopausal symptoms.
    Booth-LaForce C; Thurston RC; Taylor MR
    Maturitas; 2007 Jul; 57(3):286-95. PubMed ID: 17336473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.